AY

Amit Yeshwant Ghanekar

Active Director Designated Partner DIN 10167039
DIN 10167039 First appointment May 2023 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Total affiliations 4 Since May 2023
Shareholding value •••• Premium profile

About Amit Yeshwant Ghanekar

Data last updated:

Amit Yeshwant Ghanekar is a Designated Partner at Sky Oncology Llp (since 2023), Director at Ictc Foundation (since 2024) and Individual Subscriber at Oncotrialmatch Private Limited (since 2026), and holds 1 more current directorship. The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹18.07 Cr; the largest is Sky Oncology Llp at ₹18.06 Cr (FY 2025).

DIN 10167039
Primary Designation Designated Partner
Industry Healthcare
First Appointment 17 May 2023
Oldest Company Age 3 yrs
Largest company Sky Oncology Llp · ₹18.06 Cr (FY 2025)
Combined revenue ₹18.07 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sky Oncology Llp ACC-3452
Designated Partner03 Aug 20232023₹18.06 Cr (FY 2025)Active
Ictc Foundation U86100MH2024NPL416978
Director10 Jan 20242024₹20,000 (FY 2025)Active
Oncotrialmatch Private Limited U63119MR2026PTC479797
Individual Subscriber17 Aug 20262026Active
A&G Milap Llp ACB-2177
Designated Partner17 May 20232023Active

Board colleagues of Amit Yeshwant Ghanekar

NameDINCompanyDesignation
Rohit Ramesh Pai10266251Sky Oncology Llp , Ictc FoundationDesignated Partner
Salil Vijay Patkar09040557Sky Oncology Llp , Ictc Foundation and 1 moreDesignated Partner
Viraj Vilas Nevrekar10389819Sky Oncology Llp , Ictc FoundationDesignated Partner
Darshan Kiran JainOncotrialmatch Private LimitedIndividual Subscriber
Kshitija Shrikant Wajekar08937270Oncotrialmatch Private LimitedDirector
Kunal GoyalOncotrialmatch Private LimitedNon- Individual Subscriber
Sagar Shrikant WajekarOncotrialmatch Private LimitedIndividual Subscriber
Shreya Chandrashekhar GattaniOncotrialmatch Private LimitedIndividual Subscriber
Sonali Kisan Warade08937269Oncotrialmatch Private LimitedIndividual Subscriber
Gayatri Amit Ghanekar10167040A&G Milap LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Sky Oncology Llp
A&G Milap Llp
Ictc Foundation
Oncotrialmatch Private Limited
Premium access

Shareholding and investment profile for Amit Yeshwant Ghanekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Yeshwant Ghanekar

Amit Yeshwant Ghanekar currently holds 4 directorships: Sky Oncology Llp (Designated Partner, since 03 Aug 2023, revenue ₹18.06 Cr (FY 2025)); Ictc Foundation (Director, since 10 Jan 2024, revenue ₹20,000 (FY 2025)); Oncotrialmatch Private Limited (Individual Subscriber, since 17 Aug 2026); A&G Milap Llp (Designated Partner, since 17 May 2023).

Amit Yeshwant Ghanekar was first appointed on 17 May 2023 as Designated Partner at A&G Milap Llp. The most recent appointment on record is 17 Aug 2026 at Oncotrialmatch Private Limited.

The 2 current companies of Amit Yeshwant Ghanekar that report revenue have a combined latest revenue of ₹18.07 Cr: Sky Oncology Llp ₹18.06 Cr (FY 2025); Ictc Foundation ₹20,000 (FY 2025).

The current boards of Amit Yeshwant Ghanekar's companies include Rohit Ramesh Pai (Sky Oncology Llp), Salil Vijay Patkar (Sky Oncology Llp), Viraj Vilas Nevrekar (Sky Oncology Llp), Darshan Kiran Jain (Oncotrialmatch Private Limited), Kshitija Shrikant Wajekar (Oncotrialmatch Private Limited), Kunal Goyal (Oncotrialmatch Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available